In a preliminary clinical trial, four men with major depressive disorder were given eight weeks of treatment using a device that produces a low-frequency ultralow magnetic field environment (ELF-ELME). All patients showed improvement in their depressive symptoms and experienced no negative effects. If larger clinical trials with a control group confirm the effectiveness of the device, it could be used as an alternative treatment for patients who prefer not to take antidepressant medications.
A head-mounted device that generates an ultra-low frequency ultralow magnetic fiel rnthe publication of the results of a study in the Asian Journal of Psychiatry, it has been discovered that using a device with an Extremely Low Frequency Magnetic Environment (ELF-ELME) has shown improvements in symptoms for four male patients who have been diagnosed with major depressive disorder. This method could potentially offer a safe and noninvasive treatment option for depression in the future. The frequency of 0 to 300 Hz is believed to stimulate mitochondria and promote their renewal, although the exact interaction between magnetic fields and biological systems is not fully understood.Mitochondria are responsible for producing energy and could potentially be used to address symptoms of depression, such as fatigue. A team of researchers at Nagoya University Graduate School of Medicine and Nagoya University Hospital in Japan, led by Professor Toshiya Inada and Masako Tachibana, conducted a clinical trial with four male Japanese participants diagnosed with depression. The participants, aged between 18 and 75, were already receiving treatment. This study, known as an exploratory first-in human study, involves both the participants and the researchers being aware of the treatment being administered.Because the size of the study was small and there was no control group, the researchers were able to focus on collecting initial data to examine the safety, dosage, and potential effectiveness of a new intervention.
During the study, the participants used a head-mounted magnetic field device that exposed them to ELF-ELME for two hours a day for eight weeks. As expected, the researchers discovered that all of the patients experienced a reduction in their depression levels.
Despite the fact that the experiment was a preliminary trial with a limited number of participants and no control group, the results indicate that larger clinical trials are possible. If these trials prove to be successful, larger-scale clinical trials may be possible.to conventional treatments, this new approach has the potential to be more patient-friendly and convenient. It also has the advantage of not requiring the use of medication, which can have side effects and compliance issues.” Inada added that their research shows promising results in terms of safety and efficacy, and they are excited about the potential impact it could have on the field of depression treatment.
The team’s next steps include conducting a large-scale clinical trial to further evaluate the device’s effectiveness and safety. They are also working on fine-tuning the technology and exploring potential partnerships for commercialization.
The therapy is more convenient and has fewer expected side effects compared to current depression treatments. It could be used for patients who prefer not to take medication or in combination with other treatments such as long-term antidepressant medications, electroconvulsive therapy, and repetitive transcranial magnetic stimulation.
Â
